Catalyst OrthoScience Inc., a Naples, Fla.-based medical device company focused on the upper extremity orthopedics market, raised $12.3m in Series D financing.
The round was led by River Cities Capital and Mutual Capital Partners.
Founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., and led by Brian K. Hutchison, chairman and CEO, Catalyst OrthoScience is a shoulder replacement surgery company with a portfolio of patents and pending patents on its surgical offerings. The company recently rebranded its product portfolio with the Archer family name, received FDA 510(k) clearance and began a limited launch for the Archer R1 Reverse Shoulder System and introduced its Archer 3D Targeting imaging software for its current product offerings.
Additionally, the Archer CSR Total Shoulder System, Catalyst’s stemless, ellipsoid anatomic system, has continued rapid adoption and growth. Today, the Archer shoulder systems have been used in more than 3,000 surgeries.
FinSMEs
07/10/2021